A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Treatment-Resistant Depression Registry investigated whether adjunctive vagus nerve stimulation (VNS) with treatment as usual in depression has superior long-term outcomes compared with treatment as usual only. METHOD: This 5-year, prospective, open-label, nonrandomized, observational registry study was conducted at 61 U.S. sites and included 795 patients who were experiencing a major depressive episode (unipolar or bipolar depression) of at least 2 years' duration or had three or more depressive episodes (including the current episode), and who had failed four or more depression treatments (including ECT). Patients with a history of psychosis or rapid-cycling bipolar disorder were excluded. The primary efficacy measure was response rate, defined as a decrease of ≥50% in baseline Montgomery-Åsberg Depression Rating Scale (MADRS) score at any postbaseline visit during the 5-year study. Secondary efficacy measures included remission. RESULTS: Patients had chronic moderate to severe depression at baseline (the mean MADRS score was 29.3 [SD=6.9] for the treatment-as-usual group and 33.1 [SD=7.0] for the adjunctive VNS group). The registry results indicate that the adjunctive VNS group had better clinical outcomes than the treatment-as-usual group, including a significantly higher 5-year cumulative response rate (67.6% compared with 40.9%) and a significantly higher remission rate (cumulative first-time remitters, 43.3% compared with 25.7%). A subanalysis demonstrated that among patients with a history of response to ECT, those in the adjunctive VNS group had a significantly higher 5-year cumulative response rate than those in the treatment-as-usual group (71.3% compared with 56.9%). A similar significant response differential was observed among ECT nonresponders (59.6% compared with 34.1%). CONCLUSIONS: This registry represents the longest and largest naturalistic study of efficacy outcomes in treatment-resistant depression, and it provides additional evidence that adjunctive VNS has enhanced antidepressant effects compared with treatment as usual in this severely ill patient population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, stimulation of the vagus nerve (one of the core interoceptive neural pathways) has been successfully used as a means of treating depression (Aaronson et al., 2017).”
From Atypical interoception as a common risk factor for psychopathology: A review (2021) · cites this paper as Aaronson et al., 2017
In the citing paper
“This was even the case in patients with comorbid depression and anxiety who are frequent non-responders in trials on antidepressant drugs.”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [116]
In the citing paper
“Further, a 5-year prospective observational study which compared the effects of treatment as usual and VNS as adjunctive treatment with treatment as usual only in treatment-resistant depression, showed a better clinical outcome and a higher remission rate in the VNS group (116).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [116]
Citations
Cites
1 retracted
Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., Young, P. R., & Gallop, R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1054 · Cited by 179 · cited 1×
“Given ethical concerns about following such a severely ill patient population over a 5-year period, the registry had a naturalistic, observational design and did not randomly assign patients to the treatment groups (22, 23).”
Self-citationRetractedThe central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1976) · Medical Entomology and Zoology · Cited by 8,899
Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009) · BMJ · doi:10.1136/bmj.b2393 · Cited by 7,299
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684 · cited 1×
“TheMontgomeryÅsberg Depression Rating Scale (MADRS) (12) (administered by central raters), the Quick Inventory of Depressive Symptomatology–Self Report (QIDS-SR) (13, 14), the CGI improvement (CGI-I) score, and the patient-rated Frequency, Intensity, andBurdenofSideEffectsRating scale (15) were administered, and data…”
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 10×
“Secondary efficacy endpoints included response based on a CGI-I score of 1 or 2 at a postbaseline visit and an improvement of$50% frombaseline on theQIDS-SR; remission, based on aMADRS score #9 at a postbaseline visit, a QIDS-SR score #5 at a postbaselinevisit, andaCGI-I scoreof 1 at apostbaselinevisit; and duration o…”
MethodInfluentialThe Central Role of the Propensity Score in Observational Studies for Causal Effects
Rosenbaum, P. R., & Rubin, D. B. (1983) · Biometrika · doi:10.2307/2335942 · Cited by 3,261
Research works printed but not linked: 2
- Rush AJ, 2009, CNS Drugs, 23, 627
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
Cited by
Items 301–391 of 391
Kirby, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21514 · Cited by 1
“A 5-year observational study of patients with TRD provides additional evidence that adjunctive VNS has better clinical outcomes and higher remission rate compared with treatment as usual (Aaronson et al., 2017).”
Vagusnervstimulation — Langzeitalternative für therapieresistente Depressionen?
Maier, H. B. (2018) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-018-1980-z
Vagus Nerve Stimulation: A Treatment in Evolution
Bhat, V., & Kennedy, S. H. (2018) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000155
Richieri, R. M., Cermolacce, M., Spatola, G., Hamdi, H., & Carron, R. (2018) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2018.12.001
The Place of ECT and Related Treatments in Contemporary UK Psychiatry
Ferrier, I. N. (2019) · Cambridge University Press eBooks · doi:10.1017/9781911623175.001 · Cited by 1
Ketamine for treatment-resistant depression
Gary, A. (2019) · Nursing Made Incredibly Easy! · doi:10.1097/01.nme.0000577620.20384.d6
Rohatgi, P., Chivukula, S., Kashanian, A., & Bari, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-34906-6_14 · Cited by 2
Domenech, P. (2018) · French Journal of Psychiatry · doi:10.1016/s2590-2415(19)30035-2
Electroconvulsive Therapy and Neuromodulation Therapies
Christmas, D. M. B., & Matthews, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.018
Müller, H., & Moeller, S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.006
He, L., Xu, R., Wang, J., Zhang, L., Dong, W., & Yang, H. (2019) · Research Square · doi:10.21203/rs.2.9551/v1
Adams, J. (2021) · eScholarship@McGill (McGill) · doi:10.82308/22873
Vérgez, J. C. (2012) · Gaceta fiscal
Valluvan, D., & Parsh, B. K. (2022) · Nursing · doi:10.1097/01.nurse.0000803524.76664.83
Kavakbasi, E., & Baune, B. T. (2021) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_353_21
Garcia, R. G., & Goldstein, J. M. (2022) · Psychiatric Annals · doi:10.3928/00485713-20211222-01
Elektrokonvulsionstherapie, Hirnstimulationsverfahren
Kreuzer, P. M., Jooyandeh, S. M., Langguth, B., Kranz, G. S., Padberg, F., Kasper, S. F., & Baghai, T. C. (2017) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_32-2 · Cited by 1
Psychopharmacotherapy of Depressive Disorders
Kavakbasi, E., & Baune, B. T. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_427-1
Gorgulho, A. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-08042022-123137
he, L., Xu, R., Wang, J., Zhang, L., Dong, W., & Yang, H. (2019) · doi:10.21203/rs.2.9551/v2
Grigoroglou, C., Feltz-Cornelis, C. M. V. D., Hodkinson, A., Coventry, P. A., Zghebi, S. S., Kontopantelis, E., Bower, P., Lovell, K., Gilbody, S., Waheed, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3721165
“[2] Psychosocial interventions may serve as appropriate interventions for suicidal ideation, particularly when suicidal ideation occurs concomitantly with depression.”
BackgroundPET and SPECT Imaging of Non-pharmacological Interventions for Psychiatric Disorders
Doma, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_34
Optimizing Use of Vagus Nerve Stimulation for the Psychiatric Patient
Goldwaser, E. L., & Aaronson, S. T. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220621-01
Self-citationVagus Nerve Stimulation and Deep Brain Stimulation: The State of the Art
Aaronson, S. T. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220627-01
Self-citationDomenech, P. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.01.021 · Cited by 1
Invasive Hirnstimulationsverfahren
Kavakbasi, E., & Baune, B. T. (2022) · Springer eBooks · doi:10.1007/978-3-662-65734-8_19 · Cited by 1
Chapter 2. Psychopharmacology and Neuromodulation
Trestman, R. L., & Kablinger, A. S. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375288.lg02
Dépression résistante aux traitements
Vlaicu, M. B. ̆., & Vlaicu, A. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77862-9.00005-0
Somatic Treatments and Neuromodulation in Psychiatry
Fitzgerald, P. B., & Arns, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_144-1
Castelli, N., Cojazzi, V. M. L., Nazzi, V., & Rizzi, M. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100663
Transcutaneous Vagal Nerve Stimulation in Trauma Spectrum Psychiatric Disorders
Bremner, J. D., Wittbrodt, M. T., Gurel, N. Z., Shandhi, M. M. H., Gazi, A. H., Park, J., & Inan, O. T. (2023) · Neuromethods · doi:10.1007/978-1-0716-3465-3_8
Kavakbasi, E., & Baune, B. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00013-6
Hierarchical and Complex Pharmacotherapy Decision-Making
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.011
Drug and Physical Treatments of Depression
Williams, R. C., & Cleare, A. J. (2024) · Cambridge University Press eBooks · doi:10.1017/9781911623861.006 · Cited by 2
Device Neuromodulation and Brain Stimulation Therapies
Luccarelli, J., Henry, M., Fernandez-Robles, C. G., Cusin, C., Camprodon, J. A., & Dougherty, D. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00052-7
Self-citationDavani, A. J., Richardson, A. J. W., Vodovozov, W., & Sanghani, S. N. (2024) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2024.05.013
Chapter 48. Treatment of Depression
Collier, S. J., & Nemeroff, C. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as48
Yogarajah, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00113-3
Somatic Treatments and Neuromodulation in Psychiatry
Fitzgerald, P. B., & Arns, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_144 · Cited by 2
Gillespie, C. F., & Nemeroff, C. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00046-7
Device Neuromodulation and Brain Stimulation Therapies
Luccarelli, J., Henry, M., Fernandez-Robles, C. G., Cusin, C., Camprodon, J. A., & Dougherty, D. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11972-9.00018-1
Self-citationChapter 5. Vagus Nerve Stimulation
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379163.lg05
Chapter 33. Management of Treatment-Resistant Depression
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379620.lg33
Chapter 20. Vagus Nerve Stimulation and Deep Brain Stimulation
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379620.lg20
Chapter 18. Electroconvulsive Therapy
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379620.lg18
Chapter 10. Nonpharmacological Somatic Treatments in Current Use
(2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379569.lg10
Applications of neuromodulation and brain-computer interface in stress-related mental disorders
Song, K., YiZheng, W. A. N. G., & Liang, C. H. E. N. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0355
Bellini, H., & Brunoni, A. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_39
Wellington, J., Lam, P. Y., Ijaz, M., Ahmed, H., Sharma, V., Yu, K. C. J., Correia, I. F. S., Mizori, R., & Ahmad, M. T. (2025) · Research Square · doi:10.21203/rs.3.rs-5478895/v1
TRANSTORNO BIPOLAR: DIAGNÓSTICO E NOVAS PERSPECTIVAS NO TRATAMENTO
CUNHA, A. C., DRESSLER, I., BOANOVA, L. L., POMPERMAYER, L. D. G., ZOLET, J. P. V., RAUBER, M. K., & PASSADOR, R. J. (2025) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-247-5.1
Approches thérapeutiques : techniques de stimulation autres que les ECT
Poulet, E., & Bulteau, S. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00052-4
VNS for treatment-resistant depression
Aaronson, S. T., & Barber, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00021-9 · Cited by 2
Self-citationTreiber, M., Baune, B. T., Gramser, A., Saelens, J., Grüll, N., Rössler, K., Novak, K., Bouzouina, A., Thanarajah, S. E., Reif-Leonhard, C., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.08.31.25334709
“A large-scale registry reported a reduction of depressive symptomatology of about 50% in approximately one third of patients within the first year of VNS adjunctive to treatment as usual (Aaronson et al., 2017).”
Dubey, S. (2025) · IP Indian Journal of Neurosciences · doi:10.18231/j.ijn.74989.1761633345
“31”
Neuroimaging in Psychiatry 2023: Mood Disorders
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6998-6
Post-vagus nerve stimulation mood and cognitive burden in dual epileptic–functional seizure patients
Natarajan, V., Sandhu, R., Mazof, C. J., Odom, N., & Hong, J. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110837
The Role of Gut-Brain Signalling in Functional Responses to Chronic Social Stress
Bharwani, A. (2019) · MacSphere (McMaster University) · doi:10.71548/13689
Morphologische Veränderungen des Nervus vagus im Rahmen der unipolaren depressiven Störung
Schreiber, L. S. (2023) · Qucosa (Saxon State and University Library Dresden)
Shibah, S. R. M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5902903
Chen, S., Han, Y., Liu, Y., Li, J., Shen, Q., Li, Y., Tian, C., & Liu, Y. (2025) · Head and Neck Diseases Conflux · doi:10.71321/5nx25d85
“As a component of this system, vagus nerve stimulation is believed to enhance vagal tone, which has been linked to improved emotional regulation and alleviation of anxiety and depression symptoms [31] .”
Lähde, N. (2024) · Tampere University Institutional Repository (Tampere University) · Cited by 4
Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.
Schatzberg, A. F., & Fountoulakis, K. Ν. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260182
Doherty, S. J., Prudente, C. N., Hinds, R. A., Pierce, D., Engineer, N. D., Carrithers, J. A., Hansen, D., & Tarver, W. B. (2026) · Frontiers in Stroke · doi:10.3389/fstro.2026.1751659
Chappell, K. (2023) · theses.fr (ABES) · doi:10.70675/5afa484cz21e5z493azae47ze62ca3553104
Advances in the Clinical Application of Neurostimulation in Major Depression
Göke, K., Kaster, T. S., & Blumberger, D. M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_28
Breit, S. (2026) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20260006
Molaeizadeh, S. Z. (2026) · Communities in ADDI (University of the Basque Country)
Uda, T., Nakae, S., & Kojima, D. (2026) · Springer eBooks · doi:10.1007/978-981-92-0176-1_11
Non-invasive vagus nerve stimulation for substance use disorder: A narrative review
Thompson-Lake, D. G. Y., Snetkov, G., Johnson, L., Ait‐Daoud, N., & Mahoney, J. J. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113244
Mental Health Parity in Interventional Psychiatry: Access, Ethical and Policy Implications
Cabrera, L. Y., Fleck, L. M., & Widge, A. S. (2026) · Current Psychiatry Reports · doi:10.1007/s11920-026-01703-2
“Even with data from a registry study by Aaronson et al. [ 26 ] showing long-term enhanced antidepressant effects (> 60”
Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour
Scala, M., Magrini, E., Leccisotti, I., Serretti, A., Gonda, X., Sankar, A., Calati, R., Kasper, S. F., Altamura, M., Colizzi, M., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112888
Park, W., Kim, E., Kang, D., Kim, S., Hong, Y., Kim, D., Lee, J., Song, H., Jung, H. H., Khang, D., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530526123
Efejene, I. O., Ben-Azu, B., Eduviere, A. T., Orororo, O. C., Oyovwi, M. O., Aisuodionoe, M. E., & Busari, A. A. (2026) · Emerging Frontiers in Translational Biomedicine and Health Sciences · doi:10.66779/8w2ge276
Conway, C. R., Aaronson, S. T., Rush, A. J., Lee, Y.-C. (., Gordon, C., Shy, O., Bunker, M. T., Riva‐Posse, P., George, M. S., Zajecka, J., et al. (2026) · medRxiv · doi:10.64898/2026.07.31.26358854
Self-citationKaluza, L., Kühnel, A., Picón‐Galindo, E., Hergenröther, M., Alkhateeb, H., Michalski, S., Ribeiro, D. J. S., Schmidt, S. V., Wachten, D., & Kroemer, N. B. (2026) · BMC Psychology · doi:10.1186/s40359-026-05219-5
“In addition, prolonged VNS is effective in treatment-resistant depression [1, 76, 78], although it is not clear whether this is due to anti-inflammatory effects.”
Neuromodulation als vierte Säule in der Depressionsbehandlung: Ein Positionspapier des DZPG
Kayser, S., Barth, B., Bajbouj, M., Ehlis, A., Gerchen, M. F., Karim, A. A., Koti, J., Kroemer, N. B., Lehnhardt, F., Nickl-Jockschat, T., et al. (2026) · Der Nervenarzt · doi:10.1007/s00115-026-01999-8
Alhawwash, A., & Yoshida, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.03.742412
“VNS applications often require activation of small-diameter fibers, such as in the case of neuromodulation for epilepsy [7], depression [8], and inflammatory disorders [9].”
Biological Non-pharmacological Treatments for Bipolar Disorder
Song, M., & Lee, J. (2026) · Springer eBooks · doi:10.1007/978-981-92-1323-8_15
Biological Non-pharmacological Treatments for Depressive Disorder
Song, M., & Seo, J. S. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_16
Zhao, Y., Bai, Y., Yu, A., Jin, X., Zhang, Z., Zou, F., Ma, Q., Wang, B., Zhu, X., Yang, Z., et al. (2026) · medRxiv · doi:10.64898/2026.08.13.26360283
Patel, A., & Rajgopal, B. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2723579
Bremner, J. D., Gazi, A. H., Gurel, N. Z., Lambert, T. P., Wittbrodt, M. T., Welsh, J. W., Pearce, B. D., Vaccarino, V., Shah, A. J., & Inan, O. T. (2026) · Stress · doi:10.1080/10253890.2026.2726826
Elsharkawy, H. A., Ajon, A. B., Elsharkawy, K., & Nisar, F. (2026) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2026-108153
Macaluso, M. (2026) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000947
Feffer, K., Strauss, I., Feldman, Z., Solomon, A., Bloemhof‐Bris, E., Nega, R., Gal, G., Hadar, A., & Domany, Y. (2026) · Journal of Ect · doi:10.1097/yct.0000000000001319
Hasanieh, K. A., Zorumski, C. F., Sackeim, H. A., Bunker, M. T., Aaronson, S. T., Rush, A. J., & Conway, C. R. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00797-1
Self-citationChai, J., Li, S., Huang, J., 姚绍岩, Zhou, L., Chen, X., Liu, F., Ji, C., Chen, H., Tan, S., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1962608
Sullivan, C. R. P., Caola, L., Johnson, R., Differding, C., Randolph, A. C., Mejia, A., Balangoy, D., Widge, A. S., Henry, T. R., Nahas, Z. H., et al. (2026) · medRxiv · doi:10.64898/2026.10.27.26366559
Treatment-Resistant Depression Is Not a Single Disorder
Macaluso, M. (2026) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000965
A decision-making framework for neuromodulation modalities in psychiatric disorders
Xhima, K., Davidson, B., Nestor, S. M., Hamani, C., Giacobbe, P., & Lipsman, N. (2026) · Nature Mental Health · doi:10.1038/s44220-026-00758-7
Metadata
- Authors
- Aaronson, S. T., Sears, P., Ruvuna, F., Bunker, M., Conway, C. R., Dougherty, D. D., Reimherr, F. W., Schwartz, T. L., & Zajecka, J. M.
- Affiliations
- Rush University Medical Center (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2017-07-01
- Volume
- 174
- Issue
- 7
- Pages
- 640-648
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2599051175
- Cited by
- 381
- References
- 26
- Citations by year
- 2026: 36 · 2025: 42 · 2024: 54 · 2023: 34 · 2022: 40 · 2021: 39 · 2020: 43 · 2019: 47 · 2018: 37 · 2017: 8
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- treatment-resistant depression, vagus nerve stimulation, adjunctive therapy, response rate, remission, suicidality, bipolar depression, major depressive disorder, long-term outcomes
- MeSH terms
- Adult, Bipolar Disorder, Chronic Disease, Depressive Disorder, Major, Major Depressive Disorder, Electroconvulsive Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Registries, Treatment Outcome, Vagus Nerve Stimulation, Suicidal Ideation, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.